Global Radiopharmaceutical Market Research Report 2020

Global Radiopharmaceutical Market Research Report 2020

Table of Contents
1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Radiopharmaceutical Segment by Type
1.2.1 Global Radiopharmaceutical Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Segment by Application
1.3.1 Radiopharmaceutical Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Revenue 2015-2026
1.4.2 Global Radiopharmaceutical Sales 2015-2026
1.4.3 Radiopharmaceutical Market Size by Region: 2020 Versus 2026
2 Global Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2015-2020)
2.2 Global Radiopharmaceutical Revenue Share by Manufacturers (2015-2020)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Radiopharmaceutical Players (Opinion Leaders)
3 Radiopharmaceutical Retrospective Market Scenario by Region
3.1 Global Radiopharmaceutical Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Radiopharmaceutical Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Radiopharmaceutical Market Facts & Figures by Country
3.3.1 North America Radiopharmaceutical Sales by Country
3.3.2 North America Radiopharmaceutical Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceutical Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceutical Sales by Country
3.4.2 Europe Radiopharmaceutical Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceutical Sales by Region
3.5.2 Asia Pacific Radiopharmaceutical Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radiopharmaceutical Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceutical Sales by Country
3.6.2 Latin America Radiopharmaceutical Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceutical Sales by Country
3.7.2 Middle East and Africa Radiopharmaceutical Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radiopharmaceutical Historic Market Analysis by Type
4.1 Global Radiopharmaceutical Sales Market Share by Type (2015-2020)
4.2 Global Radiopharmaceutical Revenue Market Share by Type (2015-2020)
4.3 Global Radiopharmaceutical Price Market Share by Type (2015-2020)
4.4 Global Radiopharmaceutical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Radiopharmaceutical Historic Market Analysis by Application
5.1 Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
5.2 Global Radiopharmaceutical Revenue Market Share by Application (2015-2020)
5.3 Global Radiopharmaceutical Price by Application (2015-2020)
6 Company Profiles and Key Figures in Radiopharmaceutical Business
6.1 Bracco Imaging
6.1.1 Corporation Information
6.1.2 Bracco Imaging Description, Business Overview and Total Revenue
6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bracco Imaging Products Offered
6.1.5 Bracco Imaging Recent Development
6.2 Bayer
6.2.1 Bayer Radiopharmaceutical Production Sites and Area Served
6.2.2 Bayer Description, Business Overview and Total Revenue
6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bayer Products Offered
6.2.5 Bayer Recent Development
6.3 Mallinckrodt
6.3.1 Mallinckrodt Radiopharmaceutical Production Sites and Area Served
6.3.2 Mallinckrodt Description, Business Overview and Total Revenue
6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mallinckrodt Products Offered
6.3.5 Mallinckrodt Recent Development
6.4 Nordion
6.4.1 Nordion Radiopharmaceutical Production Sites and Area Served
6.4.2 Nordion Description, Business Overview and Total Revenue
6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Nordion Products Offered
6.4.5 Nordion Recent Development
6.5 Triad Isotopes
6.5.1 Triad Isotopes Radiopharmaceutical Production Sites and Area Served
6.5.2 Triad Isotopes Description, Business Overview and Total Revenue
6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Triad Isotopes Products Offered
6.5.5 Triad Isotopes Recent Development
6.6 Lantheus
6.6.1 Lantheus Radiopharmaceutical Production Sites and Area Served
6.6.2 Lantheus Description, Business Overview and Total Revenue
6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lantheus Products Offered
6.6.5 Lantheus Recent Development
6.7 IBA Group
6.6.1 IBA Group Radiopharmaceutical Production Sites and Area Served
6.6.2 IBA Group Description, Business Overview and Total Revenue
6.6.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.4.4 IBA Group Products Offered
6.7.5 IBA Group Recent Development
6.8 GE Healthcare
6.8.1 GE Healthcare Radiopharmaceutical Production Sites and Area Served
6.8.2 GE Healthcare Description, Business Overview and Total Revenue
6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.8.4 GE Healthcare Products Offered
6.8.5 GE Healthcare Recent Development
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Radiopharmaceutical Production Sites and Area Served
6.9.2 China Isotope & Radiation Description, Business Overview and Total Revenue
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.9.4 China Isotope & Radiation Products Offered
6.9.5 China Isotope & Radiation Recent Development
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Radiopharmaceutical Production Sites and Area Served
6.10.2 Jubilant Pharma Description, Business Overview and Total Revenue
6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Jubilant Pharma Products Offered
6.10.5 Jubilant Pharma Recent Development
6.11 Eli Lilly
6.11.1 Eli Lilly Radiopharmaceutical Production Sites and Area Served
6.11.2 Eli Lilly Radiopharmaceutical Description, Business Overview and Total Revenue
6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly Products Offered
6.11.5 Eli Lilly Recent Development
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Radiopharmaceutical Production Sites and Area Served
6.12.2 Advanced Accelerator Applications Radiopharmaceutical Description, Business Overview and Total Revenue
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Advanced Accelerator Applications Products Offered
6.12.5 Advanced Accelerator Applications Recent Development
6.13 SIEMENS
6.13.1 SIEMENS Radiopharmaceutical Production Sites and Area Served
6.13.2 SIEMENS Radiopharmaceutical Description, Business Overview and Total Revenue
6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.13.4 SIEMENS Products Offered
6.13.5 SIEMENS Recent Development
6.14 Dongcheng
6.14.1 Dongcheng Radiopharmaceutical Production Sites and Area Served
6.14.2 Dongcheng Radiopharmaceutical Description, Business Overview and Total Revenue
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Dongcheng Products Offered
6.14.5 Dongcheng Recent Development
6.15 Navidea
6.15.1 Navidea Radiopharmaceutical Production Sites and Area Served
6.15.2 Navidea Radiopharmaceutical Description, Business Overview and Total Revenue
6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Navidea Products Offered
6.15.5 Navidea Recent Development
7 Radiopharmaceutical Manufacturing Cost Analysis
7.1 Radiopharmaceutical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceutical
7.4 Radiopharmaceutical Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceutical Distributors List
8.3 Radiopharmaceutical Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Radiopharmaceutical Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Radiopharmaceutical by Type (2021-2026)
10.2 Radiopharmaceutical Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceutical by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Radiopharmaceutical by Application (2021-2026)
10.3 Radiopharmaceutical Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceutical by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Radiopharmaceutical by Region (2021-2026)
10.4 North America Radiopharmaceutical Estimates and Projections (2021-2026)
10.5 Europe Radiopharmaceutical Estimates and Projections (2021-2026)
10.6 Asia Pacific Radiopharmaceutical Estimates and Projections (2021-2026)
10.7 Latin America Radiopharmaceutical Estimates and Projections (2021-2026)
10.8 Middle East and Africa Radiopharmaceutical Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Sales (M Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Radiopharmaceutical Sales (M Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Radiopharmaceutical Market Size by Type (M Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Radiopharmaceutical Manufacturers Covered in This Study
Table 5. Global Radiopharmaceutical Sales (M Doses) by Manufacturers (2015-2020)
Table 6. Global Radiopharmaceutical Sales Share by Manufacturers (2015-2020)
Table 7. Global Radiopharmaceutical Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Radiopharmaceutical Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Radiopharmaceutical Sales Sites and Area Served
Table 11. Manufacturers Radiopharmaceutical Product Types
Table 12. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Radiopharmaceutical Players
Table 16. Global Radiopharmaceutical Sales (M Doses) by Region (2015-2020)
Table 17. Global Radiopharmaceutical Sales Market Share by Region (2015-2020)
Table 18. Global Radiopharmaceutical Revenue (Million US$) by Region (2015-2020)
Table 19. Global Radiopharmaceutical Revenue Market Share by Region (2015-2020)
Table 20. North America Radiopharmaceutical Sales by Country (2015-2020) (M Doses)
Table 21. North America Radiopharmaceutical Sales Market Share by Country (2015-2020)
Table 22. North America Radiopharmaceutical Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Radiopharmaceutical Revenue Market Share by Country (2015-2020)
Table 24. Europe Radiopharmaceutical Sales by Country (2015-2020) (M Doses)
Table 25. Europe Radiopharmaceutical Sales Market Share by Country (2015-2020)
Table 26. Europe Radiopharmaceutical Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Radiopharmaceutical Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Radiopharmaceutical Sales by Region (2015-2020) (M Doses)
Table 29. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Radiopharmaceutical Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2015-2020)
Table 32. Latin America Radiopharmaceutical Sales by Country (2015-2020) (M Doses)
Table 33. Latin America Radiopharmaceutical Sales Market Share by Country (2015-2020)
Table 34. Latin America Radiopharmaceutical Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Radiopharmaceutical Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Radiopharmaceutical Sales by Country (2015-2020) (M Doses)
Table 37. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Radiopharmaceutical Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2015-2020)
Table 40. Global Radiopharmaceutical Sales (M Doses) by Type (2015-2020)
Table 41. Global Radiopharmaceutical Sales Share by Type (2015-2020)
Table 42. Global Radiopharmaceutical Revenue (Million US$) by Type (2015-2020)
Table 43. Global Radiopharmaceutical Revenue Share by Type (2015-2020)
Table 44. Global Radiopharmaceutical Price (USD/Dose) by Type (2015-2020)
Table 45. Global Radiopharmaceutical Sales (M Doses) by Application (2015-2020)
Table 46. Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
Table 47. Global Radiopharmaceutical Sales Growth Rate by Application (2015-2020)
Table 48. Bracco Imaging Radiopharmaceutical Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Bracco Imaging Main Product
Table 52. Bracco Imaging Recent Development
Table 53. Bayer Radiopharmaceutical Corporation Information
Table 54. Bayer Corporation Information
Table 55. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Bayer Main Product
Table 57. Bayer Recent Development
Table 58. Mallinckrodt Radiopharmaceutical Corporation Information
Table 59. Mallinckrodt Corporation Information
Table 60. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Mallinckrodt Main Product
Table 62. Mallinckrodt Recent Development
Table 63. Nordion Radiopharmaceutical Corporation Information
Table 64. Nordion Corporation Information
Table 65. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. Nordion Main Product
Table 67. Nordion Recent Development
Table 68. Triad Isotopes Radiopharmaceutical Corporation Information
Table 69. Triad Isotopes Corporation Information
Table 70. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Triad Isotopes Main Product
Table 72. Triad Isotopes Recent Development
Table 73. Lantheus Radiopharmaceutical Corporation Information
Table 74. Lantheus Corporation Information
Table 75. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Lantheus Main Product
Table 77. Lantheus Recent Development
Table 78. IBA Group Radiopharmaceutical Corporation Information
Table 79. IBA Group Corporation Information
Table 80. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. IBA Group Main Product
Table 82. IBA Group Recent Development
Table 83. GE Healthcare Radiopharmaceutical Corporation Information
Table 84. GE Healthcare Corporation Information
Table 85. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. GE Healthcare Main Product
Table 87. GE Healthcare Recent Development
Table 88. China Isotope & Radiation Radiopharmaceutical Corporation Information
Table 89. China Isotope & Radiation Corporation Information
Table 90. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. China Isotope & Radiation Main Product
Table 92. China Isotope & Radiation Recent Development
Table 93. Jubilant Pharma Radiopharmaceutical Corporation Information
Table 94. Jubilant Pharma Corporation Information
Table 95. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Jubilant Pharma Main Product
Table 97. Jubilant Pharma Recent Development
Table 98. Eli Lilly Radiopharmaceutical Corporation Information
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Eli Lilly Main Product
Table 102. Eli Lilly Recent Development
Table 103. Advanced Accelerator Applications Radiopharmaceutical Corporation Information
Table 104. Advanced Accelerator Applications Corporation Information
Table 105. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. Advanced Accelerator Applications Main Product
Table 107. Advanced Accelerator Applications Recent Development
Table 108. SIEMENS Radiopharmaceutical Corporation Information
Table 109. SIEMENS Corporation Information
Table 110. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. SIEMENS Main Product
Table 112. SIEMENS Recent Development
Table 113. Dongcheng Radiopharmaceutical Corporation Information
Table 114. Dongcheng Corporation Information
Table 115. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Dongcheng Main Product
Table 117. Dongcheng Recent Development
Table 118. Navidea Radiopharmaceutical Corporation Information
Table 119. Navidea Corporation Information
Table 120. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Navidea Main Product
Table 122. Navidea Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Radiopharmaceutical Distributors List
Table 126. Radiopharmaceutical Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Radiopharmaceutical Sales (M Doses) Forecast by Type (2021-2026)
Table 131. Global Radiopharmaceutical Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Radiopharmaceutical Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Radiopharmaceutical Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Radiopharmaceutical Sales (M Doses) Forecast by Application (2021-2026)
Table 135. Global Radiopharmaceutical Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Radiopharmaceutical Sales (M Doses) Forecast by Region (2021-2026)
Table 137. Global Radiopharmaceutical Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Radiopharmaceutical Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Radiopharmaceutical
Figure 2. Global Radiopharmaceutical Sales Market Share by Type: 2020 VS 2026
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Consumption Market Share by Application: 2020 VS 2026
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Radiopharmaceutical Market Size 2015-2026 (US$ Million)
Figure 13. Global Radiopharmaceutical Sales Capacity (M Doses) (2015-2026)
Figure 14. Global Radiopharmaceutical Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Radiopharmaceutical Sales Share by Manufacturers in 2020
Figure 16. Global Radiopharmaceutical Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Revenue in 2019
Figure 18. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Radiopharmaceutical Sales Market Share by Region (2015-2020)
Figure 20. Global Radiopharmaceutical Sales Market Share by Region in 2019
Figure 21. Global Radiopharmaceutical Revenue Market Share by Region (2015-2020)
Figure 22. Global Radiopharmaceutical Revenue Market Share by Region in 2019
Figure 23. North America Radiopharmaceutical Sales Market Share by Country in 2019
Figure 24. North America Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 25. U.S. Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 26. U.S. Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 28. Canada Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Radiopharmaceutical Sales Market Share by Country in 2019
Figure 30. Europe Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 31. Germany Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 32. Germany Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 34. France Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 36. U.K. Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 38. Italy Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 40. Russia Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Radiopharmaceutical Sales Market Share by Region in 2019
Figure 42. Asia Pacific Radiopharmaceutical Revenue Market Share by Region in 2019
Figure 43. China Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 44. China Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 46. Japan Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 48. South Korea Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 50. India Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 52. Australia Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 54. Taiwan Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 56. Indonesia Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 58. Thailand Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 60. Malaysia Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 62. Philippines Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 64. Vietnam Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Radiopharmaceutical Sales Market Share by Country in 2019
Figure 66. Latin America Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 67. Mexico Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 68. Mexico Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 70. Brazil Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 72. Argentina Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Radiopharmaceutical Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country in 2019
Figure 75. Turkey Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 76. Turkey Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 78. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. U.A.E Radiopharmaceutical Sales Growth Rate (2015-2020) (M Doses)
Figure 80. U.A.E Radiopharmaceutical Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Radiopharmaceutical by Type (2015-2020)
Figure 82. Sales Market Share of Radiopharmaceutical by Type in 2019
Figure 83. Revenue Share of Radiopharmaceutical by Type (2015-2020)
Figure 84. Revenue Market Share of Radiopharmaceutical by Type in 2019
Figure 85. Global Radiopharmaceutical Sales Growth by Type (2015-2020) (M Doses)
Figure 86. Global Radiopharmaceutical Sales Market Share by Application (2015-2020)
Figure 87. Global Radiopharmaceutical Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Radiopharmaceutical by Application (2015-2020)
Figure 89. Global Revenue Share of Radiopharmaceutical by Application in 2020
Figure 90. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Triad Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. IBA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Advanced Accelerator Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Radiopharmaceutical
Figure 107. Manufacturing Process Analysis of Radiopharmaceutical
Figure 108. Radiopharmaceutical Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Radiopharmaceutical Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 113. North America Radiopharmaceutical Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Radiopharmaceutical Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Radiopharmaceutical Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Radiopharmaceutical Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Radiopharmaceutical Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Radiopharmaceutical Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Radiopharmaceutical Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Radiopharmaceutical Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Radiopharmaceutical Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs